Literature DB >> 12723917

Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study.

Joseph L Ferreira1, Susan Maslanka, Eric Johnson, Mike Goodnough.   

Abstract

An amplified enzyme-linked immunosorbent assay (amp-ELISA) was compared with the AOAC Official Method 977.26 for detection of Clostridium botulinum and its toxins in foods. Eleven laboratories participated and the results of 10 laboratories were used in the study. Two anaerobic culture media, tryptone peptone glucose yeast extract (TPGY) and cooked meat medium (CMM) were used to generate toxic samples with types A, B, E, and F botulinal strains. Nonbotulinal clostridia were also tested. The toxicity of each botulinal culture was determined by the AOAC method, and the cultures were then diluted, if necessary, to high (about 10,000 minimal lethal dose [MLD]/mL) and low (about 100 MLD/mL) test samples. The overall sensitivity of detection in TPGY and CMM cultures with the amp-ELISA was 94.7% at about 100 MLD/mL and 99.6% for samples with > or = 10,000 MLD/mL toxicity. The amp-ELISA detection sensitivity for low toxin samples was 92.3% in TPGY and 99.4% in CMM. The false-positive rate ranged from 1.5% for type A to 28.6% for type F in TPGY, and from 2.4% for type A to 11.4% for type F in CMM. Most of the cross-reactivity was due to detection of other botulinal types, especially in high toxin samples. The amp-ELISA could be used to screen suspect cultures for botulinal toxins. Positive amp-ELISA samples would be confirmed by the AOAC reference method.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723917

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  24 in total

1.  Sensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column test.

Authors:  Frank Gessler; Katrin Hampe; Helge Böhnel
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

2.  Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk.

Authors:  Lawrence M Wein; Yifan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

3.  Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Authors:  Dongxia Wang; Jakub Baudys; Yiming Ye; Jon C Rees; John R Barr; James L Pirkle; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2012-09-24       Impact factor: 3.365

4.  DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.

Authors:  Veronica L Scott; Daniel O Villarreal; Natalie A Hutnick; Jewell N Walters; Edwin Ragwan; Khalil Bdeir; Jian Yan; Niranjan Y Sardesai; Adam C Finnefrock; Danilo R Casimiro; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Evaluation of lateral-flow Clostridium botulinum neurotoxin detection kits for food analysis.

Authors:  Shashi K Sharma; Brian S Eblen; Robert L Bull; Donald H Burr; Richard C Whiting
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

6.  Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.

Authors:  D Akbulut; K A Grant; J McLauchlin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection.

Authors:  C Shone; J Ferreira; A Boyer; N Cirino; C Egan; E Evans; J Kools; S Sharma
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

8.  Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism.

Authors:  Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies.

Authors:  Marvin G Warner; Jay W Grate; Abby Tyler; Richard M Ozanich; Keith D Miller; Jianlong Lou; James D Marks; Cynthia J Bruckner-Lea
Journal:  Biosens Bioelectron       Date:  2009-06-26       Impact factor: 10.618

10.  Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A.

Authors:  Reuven Rasooly; Paula M Do
Journal:  Appl Environ Microbiol       Date:  2008-05-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.